Share-based Compensation (Tables)

3 Months Ended

Sep. 30, 2021

Share-based Compensation

Schedule of weighted average assumptions

	September 30, 2020
Risk-free interest rate		0.2	%
Expected volatility		82.5	%
Expected dividend yield		—	%
Forfeiture rate		—	%
Expected term		5.0	years
Weighted average fair value	$	3.86

Summary of stock option award activity

						Weighted
		Weighted-				Average
		Average		Aggregate		Remaining
		Exercise		Intrinsic		Contractual
(In thousands, except for weighted average price and life data)	Awards	Price		Value		Life (yrs.)
Outstanding at June 30, 2021	1,046	$	9.51	$	25	7.2
Exercised	(3)	$	3.55	$	2
Forfeited, expired or repurchased	(10)	$	3.55
Outstanding at September 30, 2021	1,033	$	9.59	$	—	7.0
Vested and expected to vest at September 30, 2021	1,033	$	9.59	$	—	7.0
Exercisable at September 30, 2021	604	$	11.94	$	—	6.1

Summary of non-vested restricted stock awards

		Weighted
		Average Grant -		Aggregate
(In thousands, except for weighted average price data)	Awards	date Fair Value		Intrinsic Value
Non-vested at June 30, 2021	1,350	$	6.75
Granted	1,110		4.14
Vested	(834)		6.07	$	3,487
Forfeited	(29)		6.67
Non-vested at September 30, 2021	1,597	$	5.29

Schedule of non-vested performance-based shares

		Weighted
		Average Grant -
(In thousands, except for weighted average price and life data)	Awards	date Fair Value
Non-vested at June 30, 2021	531	$	10.29
Granted	617	$	6.04
Performance adjustment (1)	(40)	$	17.69
Non-vested at September 30, 2021	1,108	$	7.65

(1) Represents the adjustment based on the performance of the July 2018 awards, which was below the Threshold goal level at the end of the three-year performance period.

Schedule of allocation of share-based compensation

	Three Months Ended
	September 30,
(In thousands)	2021		2020
Selling, general and administrative expenses	$	2,697	$	2,714
Research and development expenses		95		155
Cost of sales		226		473
Total	$	3,018	$	3,342
Tax benefit at statutory rate	$	679	$	752